{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:23:26Z","timestamp":1791267806339,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ando.2025.101721","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:03:38Z","timestamp":1741320218000},"page":"101721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Management of primary hyperparathyroidism in MEN1: From initial subtotal surgery to complex treatment of the remaining gland"],"prefix":"10.1016","volume":"86","author":[{"given":"Louis","family":"Schubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Melot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Delbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S\u00e9gol\u00e8ne","family":"Cottereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Koumakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fid\u00e9line","family":"Bonnet-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Groussin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2025.101721_bib0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2025.101721_bib0010","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101721_bib0015","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/hmg\/ddt039","article-title":"Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d\u2019\u00e9tude des tumeurs endocrines (GTE) cohort study","volume":"22","author":"Thevenon","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ando.2025.101721_bib0020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ando.2025.101721_bib0025","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ando.2025.101721_bib0030","doi-asserted-by":"crossref","first-page":"T119","DOI":"10.1530\/ERC-17-0199","article-title":"The future: genetics advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"Agarwal","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2025.101721_bib0035","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2025.101721_bib0040","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00428-023-03730-3","article-title":"Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors","volume":"484","author":"Brautigam","year":"2024","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ando.2025.101721_bib0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12881-017-0465-9","article-title":"Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing","volume":"18","author":"Kim","year":"2017","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.ando.2025.101721_bib0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2217\/ije.14.16","article-title":"Exploring the tumors of multiple endocrine neoplasia type 1 in mouse models for basic and preclinical studies","volume":"1","author":"Agarwal","year":"2014","journal-title":"Int J Endocr Oncol"},{"key":"10.1016\/j.ando.2025.101721_bib0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccr.2008.05.003","article-title":"Menin critically links MLL proteins with LEDGF on cancer-associated target genes","volume":"14","author":"Yokoyama","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ando.2025.101721_bib0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple endocrine neoplasia type 1: latest insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2025.101721_bib0065","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/s41588-024-01874-9","article-title":"In vivo CRISPR screens identify a dual function of MEN1 in regulating tumor-microenvironment interactions","volume":"56","author":"Su","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.ando.2025.101721_bib0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ando.2023.09.003","volume":"85","author":"Goudet","year":"2024","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ando.2025.101721_bib0075","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/SLA.0b013e31811f4467","article-title":"Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?","volume":"246","author":"Tonelli","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0080","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1530\/EC-17-0207","article-title":"MEN1 gene mutation with parathyroid carcinoma: first report of a familial case","volume":"6","author":"Cinque","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2025.101721_bib0085","doi-asserted-by":"crossref","first-page":"557050","DOI":"10.3389\/fendo.2020.557050","article-title":"Prevalence of parathyroid carcinoma and atypical parathyroid neoplasms in 153 patients with multiple endocrine neoplasia type 1: case series and literature review","volume":"11","author":"Song","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2025.101721_bib0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijsu.2016.05.035","article-title":"Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; a clinico-pathologic challenge. The MD Anderson case series and review of the literature","volume":"31","author":"Christakis","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0095","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2025.101721_bib0100","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archsurg.134.10.1119","article-title":"Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy","volume":"134","author":"Burgess","year":"1999","journal-title":"Arch Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0105","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/jbmr.125","article-title":"Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism","volume":"25","author":"Lourenco","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2025.101721_bib0110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/cen.14067","article-title":"Paediatric and young adult manifestations and outcomes of multiple endocrine neoplasia type 1","volume":"91","author":"Herath","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101721_bib0115","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d\u2019\u00e9tude des tumeurs endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101721_bib0120","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/bjs\/znac006","article-title":"Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study","volume":"109","author":"Gaujoux","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0125","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2025.101721_bib0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.6061\/clinics\/2012(Sup01)23","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?","volume":"67","author":"Giusti","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ando.2025.101721_bib0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ando.2025.101721_bib0140","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","article-title":"Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT","volume":"247","author":"Norton","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12020-017-1322-5","article-title":"MEN1 in children and adolescents: data from patients of a regional referral center for hereditary endocrine tumors","volume":"59","author":"Vannucci","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2025.101721_bib0150","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/cen.13453","article-title":"Primary hyperparathyroidism in Chinese children and adolescents: a single-centre experience at Peking Union Medical College Hospital","volume":"87","author":"Wang","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101721_bib0155","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fendo.2018.00597","article-title":"When parathyroidectomy should be indicated or postponed in adolescents with MEN1-related primary hyperparathyroidism","volume":"9","author":"Marini","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2025.101721_bib0160","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101721_bib0165","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1507\/endocrj.K09E-204","article-title":"Surgical approach in hereditary hyperparathyroidism","volume":"56","author":"Tonelli","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2025.101721_bib0170","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archsurg.135.7.844","article-title":"Preoperative sestamibi scanning and surgical findings at bilateral, unilateral, or minimal reoperation for recurrent hyperparathyroidism after subtotal parathyroidectomy in patients with multiple endocrine neoplasia type 1","volume":"135","author":"Shepherd","year":"2000","journal-title":"Arch Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0175","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1245\/s10434-016-5467-x","article-title":"Reoperative surgery in patients with multiple endocrine neoplasia type 1 associated primary hyperparathyroidism","volume":"23","author":"Keutgen","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2025.101721_bib0180","doi-asserted-by":"crossref","first-page":"T209","DOI":"10.1530\/ERC-17-0231","article-title":"The future: diagnostic and imaging advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"Manoharan","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2025.101721_bib0185","doi-asserted-by":"crossref","first-page":"122","DOI":"10.23736\/S1824-4785.23.03512-4","article-title":"Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism","volume":"67","author":"Quak","year":"2023","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ando.2025.101721_bib0190","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/jamaoto.2024.1421","article-title":"F18-choline PET\/CT or MIBI SPECT\/CT in the surgical management of primary hyperparathyroidism: a diagnostic randomized clinical trial","volume":"150","author":"Quak","year":"2024","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0195","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1007\/s00268-020-05695-9","article-title":"(18)F-fluorocholine PET\/CT in MEN1 patients with primary hyperparathyroidism","volume":"44","author":"Gauthe","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.23736\/S1824-4785.22.03440-9","article-title":"Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET\/CT. Illustrative cases and pitfalls","volume":"66","author":"Talbot","year":"2022","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ando.2025.101721_bib0205","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00259-023-06537-1","article-title":"Performance of [(18)F]fluorocholine PET\/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent\/recurrent disease","volume":"51","author":"Boucher","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ando.2025.101721_bib0210","doi-asserted-by":"crossref","first-page":"101699","DOI":"10.1016\/j.ando.2025.101699","article-title":"Chapter 10: what parathyroid imaging is required for hyprepratahyroidism?","volume":"86","author":"Chevalier","year":"2025","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ando.2025.101721_bib0215","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1210\/js.2018-00193","article-title":"Visualization of macroprolactinoma by (18)F-fluorocholine PET\/CT in a patient with multiple endocrine neoplasia type 1","volume":"2","author":"Paepegaey","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ando.2025.101721_bib0220","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1007\/s00259-024-06846-z","article-title":"(68)Ga-Trivehexin PET\/CT: a promising novel tracer for primary hyperparathyroidism","volume":"51","author":"Kuyumcu","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ando.2025.101721_bib0225","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s12020-024-03790-8","article-title":"Quality appraisal of clinical practice guidelines for the evaluation and management of primary hyperparathyroidism","volume":"85","author":"Salmon","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2025.101721_bib0230","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0235","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","article-title":"The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review","volume":"35","author":"Schreinemakers","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0240","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","article-title":"Primary hyperparathyroidism in MEN1 patients: a cohort study with long-term follow-up on preferred surgical procedure and the relation with genotype","volume":"255","author":"Pieterman","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0245","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.surg.2014.08.006","article-title":"A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"156","author":"Lairmore","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2025.101721_bib0250","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.surg.2017.07.023","article-title":"Disease and treatment factors associated with lower quality of life scores in adults with multiple endocrine neoplasia type I","volume":"162","author":"Goswami","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2025.101721_bib0255","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s12325-021-01649-2","article-title":"Risk of nephrolithiasis and nephrocalcinosis in patients with chronic hypoparathyroidism: a retrospective cohort study","volume":"38","author":"Ketteler","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.ando.2025.101721_bib0260","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.surg.2010.07.037","article-title":"Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy","volume":"148","author":"Melck","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2025.101721_bib0265","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/SLA.0000000000005980","article-title":"Recurrence after surgery for primary hyperparathyroidism in 517 patients with multiple endocrine neoplasia type 1: an Association francophone de chirurgie endocrinienne and Groupe d\u2019\u00e9tude des tumeurs Endocrines study","volume":"279","author":"Santucci","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0270","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1038\/s41598-020-67424-5","article-title":"Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism","volume":"10","author":"Choi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ando.2025.101721_bib0275","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1007\/s00268-016-3624-9","article-title":"Unilateral clearance for primary hyperparathyroidism in selected patients with multiple endocrine neoplasia type 1","volume":"40","author":"Kluijfhout","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2025.101721_bib0280","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cen.14112","article-title":"Single gland excision for MEN1-associated primary hyperparathyroidism","volume":"92","author":"Manoharan","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101721_bib0285","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2302892","article-title":"Health consequences of thymus removal in adults","volume":"389","author":"Kooshesh","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2025.101721_bib0290","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncpendmet0816","article-title":"A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet","volume":"4","author":"Falchetti","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101721_bib0295","doi-asserted-by":"crossref","first-page":"906163","DOI":"10.1155\/2010\/906163","article-title":"Clinical use of cinacalcet in MEN1 hyperparathyroidism","volume":"2010","author":"Moyes","year":"2010","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.ando.2025.101721_bib0300","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/EJE-12-0117","article-title":"MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly","volume":"167","author":"Filopanti","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101721_bib0305","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-015-0696-5","article-title":"Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to multiple endocrine neoplasia syndrome type 1 (MEN1)","volume":"52","author":"Giusti","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2025.101721_bib0310","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.3390\/jcm11071967","article-title":"Management and long-term follow-up of hyperparathyroidism in multiple endocrine neoplasia type 1: single center experience","volume":"11","author":"Yavropoulou","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ando.2025.101721_bib0315","doi-asserted-by":"crossref","first-page":"926986","DOI":"10.3389\/fped.2022.926986","article-title":"Off-label use of cinacalcet in pediatric primary hyperparathyroidism: a French multicenter experience","volume":"10","author":"Bernardor","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ando.2025.101721_bib0320","first-page":"835","article-title":"Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism","volume":"36","author":"Liu","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ando.2025.101721_bib0325","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3348\/kjr.2021.0716","article-title":"Efficacy and safety of ultrasound-guided radiofrequency ablation for primary hyperparathyroidism: a prospective study","volume":"23","author":"Chai","year":"2022","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.ando.2025.101721_bib0330","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/02656736.2022.2047231","article-title":"Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation","volume":"39","author":"Peng","year":"2022","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ando.2025.101721_bib0335","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2265.2008.03238.x","article-title":"Percutaneous ethanol injection therapy: a surgery-sparing treatment for primary hyperparathyroidism","volume":"69","author":"Stratigis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101721_bib0340","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1210\/clinem\/dgab240","article-title":"Effectiveness and safety of thermal ablation in the treatment of primary hyperparathyroidism: a multicenter study","volume":"106","author":"Wei","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101721_bib0345","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3348\/kjr.2019.0593","article-title":"Clinical study on safety and efficacy of microwave ablation for primary hyperparathyroidism","volume":"21","author":"Wei","year":"2020","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.ando.2025.101721_bib0350","doi-asserted-by":"crossref","first-page":"101700","DOI":"10.1016\/j.ando.2025.101700","article-title":"Chapter 11: treatment modalities","volume":"86","author":"Baud","year":"2025","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ando.2025.101721_bib0355","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.3390\/diagnostics12102553","article-title":"Ultrasound-guided radiofrequency ablation for primary hyperparathyroidism induced by multiple endocrine neoplasia 1-a case report","volume":"12","author":"Han","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ando.2025.101721_bib0360","doi-asserted-by":"crossref","first-page":"2308056","DOI":"10.1080\/02656736.2024.2308056","article-title":"Microwave ablation for recurrent primary hyperparathyroidism in four patients with multiple endocrine neoplasia type 1: a case series report","volume":"41","author":"Tan","year":"2024","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ando.2025.101721_bib0365","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1210\/jc.2014-3255","article-title":"Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1","volume":"100","author":"Singh Ospina","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101721_bib0370","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.2214\/AJR.07.3431","article-title":"Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1","volume":"191","author":"Veldman","year":"2008","journal-title":"AJR Am J Roentgenol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342662500040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342662500040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T12:51:00Z","timestamp":1751028660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000342662500040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S000342662500040X"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2025.101721","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of primary hyperparathyroidism in MEN1: From initial subtotal surgery to complex treatment of the remaining gland","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2025.101721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101721"}}